AVITA Medical (RCEL) Gross Margin (2018 - 2025)

AVITA Medical's Gross Margin history runs 8 years deep, the most recent figure standing at 15.56% for Q4 2025.

• Quarterly Gross Margin fell 7380.0% year-over-year to 15.56% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 40.44% (down 4589.0% YoY) and the FY2025 annual result came in at 82.13%, down 419.0% from the prior year.
• Gross Margin was 15.56% for Q4 2025 at AVITA Medical, down from 82.12% in the prior quarter.
• Across five years, Gross Margin topped out at 89.35% in Q4 2024 and bottomed at 15.56% in Q4 2025.
• A 5-year average of 79.26% and a median of 83.43% in 2024 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2023 — Gross Margin soared 778 bps — and 2025, when it plunged 7380 bps.
• AVITA Medical's Gross Margin stood at 79.73% in 2021, then advanced by 8 bps to 85.75% in 2022, then grew by 2 bps to 87.35% in 2023, then gained by 2 bps to 89.35% in 2024, then tumbled by 83 bps to 15.56% in 2025.
• Business Quant data shows RCEL's Gross Margin at 15.56% in Q4 2025, 82.12% in Q3 2025, and 82.02% in Q2 2025.